Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTIC | AUPH | ELVN | ||
| Company | Cti Biopharm Corp | Aurinia Pharm Ord | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.10 | 8.77 | 24.21 | ||
| High | 9.10 | 8.96 | 25.37 | ||
| Low | 9.09 | 8.52 | 24.00 | ||
| Last | 9.09 | 8.54 | 24.42 | ||
| Change | unch | -0.23 | +0.52 | ||
| % Change | unch | -2.62% | +2.20% | ||
| Volume | 11,420,900 | 1,604,800 | 249,200 | ||
| 20-Day Average Volume | 3,402,150 | 1,417,470 | 196,220 | ||
| Previous Close | 9.09 | 8.77 | 23.90 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.06 | 9.24 | 23.39 | ||
| 20-Day Raw Stochastic | 88.89% | 0.93% | 66.15% | ||
| 20-Day Relative Strength | 80.92% | 47.02% | 50.92% | ||
| Weighted Alpha | +5.50 | +33.07 | +21.29 | ||
| Today's Opinion | 100% Buy | 80% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 06/15/23 | -7.68% since 12/26/24 | +7.55% since 12/26/24 | ||
| Low | 9.07 on 06/20/23 | 8.52 on 01/03/25 | 21.55 on 12/30/24 | ||
| High | 9.10 on 06/23/23 | 9.31 on 12/30/24 | 25.37 on 01/03/25 | ||
| 1-Month | |||||
| %Chg | +1.11% since 05/23/23 | -3.50% since 12/03/24 | +3.45% since 12/03/24 | ||
| Low | 8.98 on 05/24/23 | 8.52 on 01/03/25 | 21.42 on 12/23/24 | ||
| High | 9.10 on 06/23/23 | 10.67 on 12/10/24 | 25.96 on 12/06/24 | ||
| 3-Month | |||||
| %Chg | +111.40% since 03/23/23 | +21.65% since 10/03/24 | -4.25% since 10/03/24 | ||
| Low | 4.01 on 04/06/23 | 6.64 on 10/10/24 | 21.42 on 12/23/24 | ||
| High | 9.10 on 06/23/23 | 10.67 on 12/10/24 | 30.03 on 10/18/24 | ||
| 6-Month | |||||
| %Chg | +61.46% since 12/23/22 | +56.12% since 07/03/24 | +13.34% since 07/03/24 | ||
| Low | 4.01 on 04/06/23 | 5.20 on 08/06/24 | 20.83 on 08/12/24 | ||
| High | 9.10 on 06/23/23 | 10.67 on 12/10/24 | 30.03 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,198,789 | 1,222,749 | 1,193,381 | ||
| Shares Outstanding, K | 131,880 | 143,179 | 48,859 | ||
| Annual Sales | 53,950,000 | 175,510,000 | 0 | ||
| Annual Net Income | -92,990,000 | -78,020,000 | -71,580,000 | ||
| Last Quarter Sales | 24,120,000 | 67,770,000 | 0 | ||
| Last Quarter Net Income | -13,420,000 | 14,350,000 | -23,160,000 | ||
| 60-Month Beta | 0.83 | 1.24 | 1.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/15/23 | 0.10 on 11/07/24 | -0.48 on 11/13/24 | ||
| Latest Earnings Date | 08/14/23 | 02/20/25 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||